FDA Approves Bristol-Myers Squibb's Glucovance
Glucovance is a combination of two oral diabetes medicines that help control blood sugar levels. Glucovance is for people with type 2 diabetes who do not use daily insulin injections. This medication is not for treating type 1 diabetes.
GLUCOVANCE (Glyburide and Metformin HCl) Tablets is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Glucovance, as an adjunct with diet and exercise, is used to treat type 2 diabetes. This drug combines two glucose-lowering drugs, glyburide and metformin. Glyburide lowers blood sugar primarily by causing more of the body's own insulin to be released, and metformin lowers blood sugar, in part, by helping your body use your own insulin more effectively.
This anti-diabetic medication is a combination of 2 drugs (glyburide and metformin). It is used along with a diet and exercise program to control high blood sugar in patients with type 2 diabetes (non-insulin-dependent diabetes).
Glyburide is a sulfonylurea and works by stimulating the release of your body's natural insulin and by decreasing the amount of sugar that your liver makes. Metformin is a biguanide and works by decreasing the amount of sugar that your liver makes and that your stomach/intestines absorb. Both of these medications work by helping to restore your body's proper response to the insulin you naturally produce.